(Q40361574)

19 September 2017

title

Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis (English)

1 reference

19 September 2017

0 references

0 references

0 references

1 reference

Sabine Steffens

1

1 reference

19 September 2017

François Mach

series ordinal

2

1 reference

19 September 2017

publication date

1 January 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

2

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

49-53

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Molecular biology of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The cannabinoid system and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Evidence for novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

PPAR-gamma: a nuclear receptor with affinity for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Pharmacokinetics of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The pharmacokinetics of THC in fat and brain: resulting functional responses to marihuana smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The complexities of the cardiovascular actions of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Endocannabinoids as cardiovascular modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Blood pressure regulation by endocannabinoids and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Triggering myocardial infarction by marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

The endogenous cannabinoid system protects against colonic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.1.49

21 January 2018

Identifiers

DOI

10.2217/14796678.2.1.49

1 reference

19 September 2017

1 reference